English  |  正體中文  |  简体中文  |  Total items :2822924  
Visitors :  30076997    Online Users :  986
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"morel c"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-4 of 4  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-05-13T08:04:17Z Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria Chen G.-J.; Pan S.-C.; Foo J.; Morel C.; Chen W.-T.; JANN-TAY WANG
臺大學術典藏 2019 Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria Chen W.-T.; Wang J.-T.; Morel C.; Foo J.; SUNG-CHING PAN; Chen G.-J.; Chen G.-J.;Sung-Ching Pan;Foo J.;Morel C.;Chen W.-T.;Wang J.-T.
臺大學術典藏 2019 Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria Chen W.-T.; Wang J.-T.; Morel C.; Foo J.; SUNG-CHING PAN; Chen G.-J.; Chen G.-J.;Sung-Ching Pan;Foo J.;Morel C.;Chen W.-T.;Wang J.-T.
臺大學術典藏 2019 Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria Chen G.-J.; Pan S.-C.; Foo J.; Morel C.; Chen W.-T.; JANN-TAY WANG

Showing items 1-4 of 4  (1 Page(s) Totally)
1 
View [10|25|50] records per page